| |
CELATOR PHARMACEUTICALS APPOINTS SCOTT JACKSON AS CEO |
|
| 5/9/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
FIVE PRIME REPORTS DISCOVERY OF IL-34, A NOVEL CYTOKINE |
|
| 5/8/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
ESPERION THERAPEUTICS COMPLETES $22.75M SERIES A FINANCING |
|
| 5/1/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
NUON THERAPEUTICS INC. COMPLETES $27M SERIES B FINANCING |
|
| 4/28/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
OREXIGEN COMPLETES ENROLLMENT OF SECOND PHASE III CONTRAVE TRIAL |
|
| 4/22/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
TARGETRX COMPLETES $9.6MM FINANCING ROUND |
|
| 4/7/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
ORQIS MEDICAL PRESENTS MOMENTUM TRIAL RESULTS AT ACC |
|
| 4/1/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
DIOBEX ANNOUNCES PRESENTATION OF SCIENTIFIC POSTER AT ANNUAL MEETING OF AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS |
|
| 4/1/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
FDA ACCEPTS ZOGENIX NDA FILING |
|
| 3/19/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
DIOBEX AND CAMURUS SIGN LICENSE AGREEMENT FOR THE DEVELOPMENT OF DIO-901 IN FLUIDCRYSTAL EXTENDED RELEASE TECHNOLOGY |
|
| 3/18/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
ALIMERA SCIENCES CLOSES $30 MILLION SERIES C FINANCING |
|
| 3/18/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
SCIELE PHARMA ACQUIRES TWINJECT FROM VERUS PHARMACEUTICALS |
|
| 3/13/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
PHARMION SHAREHOLDERS APPROVE ACQUISTION BY CELGENE |
|
| 3/6/2008 |
|
|
more
|
| |
| |
|
|
| |
| |
CELGENE TO ACQUIRE PHARMION FOR $2.9B |
|
| 11/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
CELGENE TO ACQUIRE PHARMION FOR $2.9B |
|
| 11/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
CELGENE TO ACQUIRE PHARMION FOR $2.9B |
|
| 11/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
CELGENE TO ACQUIRE PHARMION FOR $2.9B |
|
| 11/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
CELGENE TO ACQUIRE PHARMION FOR $2.9B |
|
| 11/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
OREXIGEN RELEASES SUMMARY OF POSITIVE PHASE 2B CONTRAVE RESULTS IN OBESITY |
|
| 10/21/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
VERUS DIVESTS PEDIATRIC ASTHMA PROGRAM TO ASTRAZENECA |
|
| 10/8/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
VANDA SUBMITS NDA FOR ILOPERIDONE FOR SCHIZOPHRENIA |
|
| 10/8/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
ESPRIT PHARMA TO BE ACQUIRED BY ALLERGAN FOR $370M |
|
| 9/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
CELATOR CLOSES $10M SERIES B FOLLOW-ON |
|
| 8/10/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
MERCK ACQUIRES NOVACARDIA FOR $350M PLUS CASH |
|
| 7/25/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
NOVALAR'S NV-101 NDA APPROVED |
|
| 6/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
APNEX MEDICAL, INC. RAISES $16.1 MILLION IN SERIES 'A' FINANCING |
|
| 5/14/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
MARINUS INITIATES PHASE IIB STUDY OF GANAXOLONE FOR ADULT PARTIAL SEIZURES |
|
| 5/10/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
OREXIGEN THERAPEUTICS ANNOUNCES PRICING OF ITS INITIAL PUBLIC OFFERING |
|
| 4/27/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
ALIMERA SCIENCES' MEDIDUR(TM) TRIAL EXCEEDS 500 PATIENT MARK IN PHASE 3 TRIAL ENROLLMENT |
|
| 4/24/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
SYNDAX PHARMACEUTICALS LICENSES SELECTIVE HDAC INHIBITOR |
|
| 4/13/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
GENVAULT CORPORATION RAISES $18M FINANCING |
|
| 4/4/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
SYNDAX PHARMACEUTICALS CLOSES $40M SERIES A FINANCING |
|
| 4/3/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
DIOBEX ANNOUNCES SUCCESSFUL COMPLETION OF PHASE 2A TRIAL OF DIO-902, A NOVEL CORTISOL SYNTHESIS INHIBITOR FOR TYPE 2 DIABETES |
|
| 3/27/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
NOVALAR'S NV-101 PRODUCES POSITIVE PHASE II AND III RESULTS |
|
| 3/23/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
TRAGARA PHARMACEUTICALS ANNOUNCES CORPORATE LAUNCH AND SERIES A FINANCING |
|
| 3/14/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
VENTIRX SECURES $28.9MM SERIES A FINANCING |
|
| 3/7/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
FDA ACCEPTS PHARMION MYELOMA DRUG FOR REVIEW |
|
| 3/2/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
ALTEA THERAPEUTICS REPORTS POSITIVE RESULTS FOR BASAL INSULIN TRANSDERMAL PATCH- DIABETES THERAPY |
|
| 3/2/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
ALTEA THERAPEUTICS REPORTS POSITIVE RESULTS FOR BASAL INSULIN TRANSDERMAL PATCH- DIABETES THERAPY |
|
| 3/2/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
CoDa THERAPEUTICS SECURES $10M IN ADDITIONAL SERIES A FINANCING |
|
| 2/22/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
PHARMION ANNOUNCES FDA ACCEPTANCE OF IND FOR ORAL AZACITIDINE |
|
| 1/31/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
PHARMION CORPORATION ANNOUNCES FDA APPROVAL OF VIDAZA NDA SUPPLEMENT FOR IV ADMINISTRATION |
|
| 1/30/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
ZOGENIX: NEW SPECIALTY PHARMA DIVES INTO COMPETITIVE MIGRAINE MARKET |
|
| 1/29/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
ALTEA REPORTS POSITIVE PHASE I RESULTS FOR BASAL INSULIN PATCH |
|
| 1/26/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
PHARMION SUBMITS EUROPEAN MARKETING AUTHORIZATION APPLICATION FOR THALIDOMIDE PHARMION(R) FOR UNTREATED MULTIPLE MYELOMA |
|
| 1/24/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
VANDA PHARMACEUTICALS ANNOUNCES PRICING OF FOLLOW-ON OFFERING OF 3,800,000 SHARES OF COMMON STOCK |
|
| 1/22/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
IOMAI AWARDED FUNDING TO DEVELOP DOSE-SPARING PATCH FOR USE IN AN INFLUENZA PANDEMIC |
|
| 1/19/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
NEOSE TECHNOLOGIES PRESENTS POSITIVE PHASE I NE-180 CLINICAL TRIAL DATA |
|
| 1/5/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
CEREXA TO BE ACQUIRED BY FOREST LABS FOR $480 MILLION PLUS POTENTIAL $100 MILLION IN MILESTONES |
|
| 1/5/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
FIVEPRIME ENTERS OSTEOARTHRITIS AND PULMONARY FIBROSIS COLLABORATION WITH CENTOCOR |
|
| 1/3/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
ALIMERA RECEIVES U.S. FDA APPROVAL TO MARKET ALAWAY FOR EYE ITCH RELIEF |
|
| 1/2/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
SOMAXON REPORTS RESULTS NOT SIGNIFICANT IN TRIAL OF ORAL NALMEFENE IN PATHOLOGICAL GAMBLING |
|
| 1/2/2007 |
|
|
more
|
| |
| |
|
|
| |
| |
ALIMERA SCIENCES COMPLETES SECOND TRANCHE OF SERIES B FINANCING, RECEIVES $15.9 MILLION |
|
| 12/22/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
NIPPON SHINYAKU, PHARMION ANNOUNCE LICENSE AGREEMENT FOR VIDAZA FOR MYELODYSPLASTIC SYNDROMES |
|
| 12/22/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
BAUSCH & LOMB BUYS ALIMERA PRODUCT LINE |
|
| 12/20/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
OREXIGEN THERAPEUTICS FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING |
|
| 12/20/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
SOMAXON'S SILENOR DEMONSTRATES POSITIVE RESULTS IN LONG-TERM PHASE 3 TRIAL IN ELDERLY PATIENTS WITH INSOMNIA |
|
| 12/18/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
FOREST LABORATORIES TO ACQUIRE ANTIBIOTIC FIRM CEREXA FOR $480 MILLION |
|
| 12/15/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
PHARMION CANCER THERAPY INDUCES CLINICAL RESPONSE |
|
| 12/13/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
AESTHETIC SCIENCES COMPLETES SERIES-A $6 MILLION FUNDING |
|
| 11/28/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
OREXIGEN THERAPEUTICS COMPLETES $30MILLION SERIES C FINANCING |
|
| 11/22/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
PHARMION AND NIPPON SHINYAKU ANNOUNCE LICENSING AGREEMENT FOR VIDAZA IN JAPAN |
|
| 11/21/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
SOMAXON'S SILENOR DEMONSTRATES POSITIVE RESULTS IN THIRD PHASE 3 TRIAL IN INSOMNIA |
|
| 11/20/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
VANDA PHARMACEUTICALS VEC-162 DEMONSTRATES POSITIVE RESULTS IN A PHASE III TRANSIENT INSOMNIA CLINICAL TRIAL |
|
| 11/16/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
NEOSE ANNOUNCES INITIATION OF PHASE I TRIAL OF GLYCOPEG-GCSF |
|
| 11/9/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
OREXIGEN ANNOUNCES ISSUANCE OF BROAD PATENTS COVERING COMPOSITION OF ITS LEAD ANTI-OBESITY COMPOUNDS |
|
| 11/9/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
SKINMEDICA AND GALDERMA TO CO-PROMOTE DESONATE |
|
| 11/7/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
NOVACEA INITIATES PHASE I/II TRIAL OF AQ4N IN GLIOBLASTOMA MULTIFORME |
|
| 11/1/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
SOMAXON'S SILENOR DEMONSTRATES POSITIVE PHASE III RESULTS IN TRANSIENT INSOMNIA |
|
| 10/24/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
SKINMEDICA ANNOUNCES FDA APPROVAL OF DESONATE GEL FOR ATOPIC DERMATITIS |
|
| 10/23/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
OREXIGEN REPORTS POSITIVE PHASE II RESULTS FOR EXCALIA COMBINATION THERAPY TO TREAT OBESITY |
|
| 10/23/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
NORTHSTAR NEUROSCIENCE REPORTS CLINICAL TRIAL MILESTONES FOR THE THIRD QUARTER 2006 |
|
| 10/10/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
CODA THERAPEUTICS ANNOUNCES SERIES A FINANCING |
|
| 10/10/2006 |
|
|
more
|
| |
| |
|
|
| |
| |
OREXIGEN THERAPEUTICS REPORTS POSITIVE 24-WEEK RESULTS FOR CON |
